Donor support sparks crucial advances in pancreatic research
The Brenden-Colson Center for Pancreatic Care has leveraged exceptional philanthropic support to achieve great advances in the detection and treatment of pancreatic cancer and disease.
The Brenden-Colson Center for Pancreatic Care has leveraged exceptional philanthropic support to achieve great advances in the detection and treatment of pancreatic cancer and disease.
The W. M. Keck Foundation has awarded research duo Catherine Galbraith, Ph.D., and James Galbraith, Ph.D., $1 million over three years to develop a one-of-a-kind imaging and computational system. Their system will seek to decode molecular aggregates — collections of proteins or ribonucleic acid that frequently rearrange inside cells and are involved in cellular information processing.
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could mean.
Vivek Unni, MD, PhD, is the inaugural John Hammerstad, MD, Professor of Basic Research of Movement Disorders and the interim director for the Jungers Center for Neurosciences Research. He joined the Department of Neurology and the OHSU Parkinson Center and Movement Disorders Program in 2011. Before coming to OHSU, Unni was an instructor in neurology […]
Cindy McEvoy, MD, MCR, is a physician-scientist whose research focuses on improving lung function for preterm infants — even after they leave the hospital.
Hear from OHSU Knight Cancer Institute researchers, physicians and supporters about what it looks like to end cancer as we know it.
Everyone has a story. And many stories at OHSU have been made possible by the generosity of donors.
The Elks Children’s Eye Clinic opened in December 2020 as the first free-standing eye institute for pediatric patients to advance work in children’s eye care.
After months of shutdown, OHSU labs are beginning to resume research efforts that were stalled by the pandemic. We explore what scientists’ ‘new normal’ looks like now.